GlassScriptPhysician profile
Ajay Kailas
NPI 1053809715
$1,657.11
in general payments reported to CMS, 2019-2025
17 companies · $57.00 in 2025
The $57.00 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $185 · 2023: $1,040 · 2024: $375 · 2025: $57.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,472.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $377.29 | 2023-2024 | Tremfya |
| Abbvie INC. | $264.67 | 2023-2024 | |
| Dermavant Sciences, INC. | $194.22 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $113.00 | 2022-2024 | Dupixent |
| Genzyme Corporation | $101.34 | 2023-2024 | |
| Mayne Pharma Commercial LLC | $97.66 | 2022-2025 | |
| Lilly USA, LLC | $93.75 | 2022-2024 | Taltz, Olumiant |
| Ucb, INC. | $85.21 | 2022-2024 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $63.94 | 2023-2024 | |
| Leo Pharma INC. | $58.31 | 2022-2023 | Adbry |
| Amgen INC. | $56.03 | 2023-2024 | Otezla |
| Sun Pharmaceutical Industries INC. | $45.52 | 2023 | Ilumya |
| Incyte Corporation | $33.95 | 2022-2023 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.65 | 2024 | Cabtreo |
| Organon LLC | $18.66 | 2025 | Vtama |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.80 | 2023 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $14.11 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Kailas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.